GENERI BIOTECH s.r.o.
Machkova 587,
50011
Hradec Kralove
Czechia
Czechia
This company is co-exhibitor of
Ceska agentura na podporu obchodu CzechTrade
Location
Hall map
Fairground map
Our range of products
Product categories
- 03 Diagnostic Tests
- 03.06 Genetic testing, molecular diagnostics
- 03.06.01 DNA testing
DNA testing
- 03 Diagnostic Tests
- 03.06 Genetic testing, molecular diagnostics
- 03.06.03 Polymerase chain reaction (PCR)
Polymerase chain reaction (PCR)
Our products
BCR-ABL1 detection / IVD kits for oncology
In the category of CE IVD kits for oncology, we present our comprehensive portfolio of products for one-step real-time RT-PCR detection and quantification of BCR-ABL1 fusion transcripts.
gb ONCO BRAF (V600E)
The CE IVD kit used to detect and quantify the BRAF V600E, E2, D somatic mutation in human genomic DNA. The detection principle is based on real-time PCR using fluorescently labeled probes and allele specific primers.
IVD kits for pharmacogenetics
We develop and produce CE IVD real-time PCR kits that are used for in vitro genotypization before an appropiate treatment of disease starts.
gb PHARM TPMT
The CE IVD real-time PCR kit intended for detection of TPMT*2, TPMT*3A, TPMT*3B and TPMT*3C in TPMT gene in human genomic DNA by real-time PCR method (allelic discrimination).
gb PHARM CYP2C19
The CE IVD real-time PCR kit intended for detection of CYP2C19*2, CYP2C19*3 and CYP2C19*17 gene mutation. The detection principle is based on a real-time PCR method (allelic discrimination).
IVD kits for human genetics
CE IVD real-time PCR kits for genetics are being used for examination of the most common monogenic diseases of clinical significance.
gb GENETIC HFE
The CE IVD real-time PCR kit intended for detection of mutations C282Y, H63D and S65C in the gene HFE in human genomic DNA. Detection is based on real-time PCR method (allelic discrimination).
gb GENETIC LACTO
The CE IVD kit intended for detection of mutations LCT (C13910T) and LCT (G22018A) in the lactase gene in human genomic DNA. Detection is based on real-time PCR method (allelic discrimination).
IVD kits for thrombophilic mutations
We present a comprehensive portfolio of “thrombophilic” CE IVD real-time PCR kits: starting with extensively used FII and FV detection kits to very special kits such as PAI1 and EPCR kits
gb HEMO FV (G1691A)
The CE IVD kit intended for detection of mutation G1691A (Leiden) in coagulation factor V in human genomic DNA. Detection is based on real-time PCR method (allelic discrimination).
gb HEMO PAI1 (4G/5G)
The CE IVD kit intended for detection of mutation 4G/5G in PAI1 gene promotor in human genomic DNA. Detection is based on real-time PCR method (allelic discrimination).
gb MICRO Aspergillus
The CE IVD real-time PCR kit intended for detection and quantification of pathogenic DNA of the most commonly occurring species of Aspergillus - A. fumigatus, A. flavus, A. niger and A. terreus by real-time PCR method.
Product category: Polymerase chain reaction (PCR)
Life Sciences products
Our product line Life Sciences comprises the most commonly used products for molecular biology such as DNA isolation kits, PCR Master Mixes, OneStep RT-qPCR Kits and Reverse Transcription Kits. It also includes assays specialized for real-time PCR analysis (assays for reference genes, custom-made assays and Customized High-Throughput PCR/qPCR Arrays).
Product category: Polymerase chain reaction (PCR)
gb IPC PCR Master Mix
gb IPC PCR Master Mix is intended for real-time PCR applications with fluorescently labelled probes and with high sensitivity and efficiency request. Its advantages are the presence of internal positive control used to check the correctness of PCR, and also increased resistance towards PCR inhibitors.
About us
Company details
GENERI BIOTECH s.r.o. is a Czech biotechnological company focusing its development, manufacturing and services on:
ONCO – kits for oncology
PHARM – kits for detection of pharmacogenetically important mutations
HEMO – kits for detection of thrombophilic mutations
GENETIC – kits for medical genetics
MICRO – kits for detection of microorganisms
oligonucleotides
qPCR probes
PCR reagents
DNA extraction kits
testing for drug development in the phases: drug discovery, preclinical and clinical testing
quality control in pharmaceutical production of biologicals
for market segment: science
cytotoxicity testing
cell lines authentication
detection of mycoplasma
for market segment: public
paternity testing
testing of genetic origin
for market segment: government institutions
expert institute services
- manufacture of in vitro diagnostic kits for molecular biology | ISO 13485
ONCO – kits for oncology
PHARM – kits for detection of pharmacogenetically important mutations
HEMO – kits for detection of thrombophilic mutations
GENETIC – kits for medical genetics
MICRO – kits for detection of microorganisms
- manufacture of products for molecular biology | ISO 9001
oligonucleotides
qPCR probes
PCR reagents
DNA extraction kits
- testing and QC services | ISO/IEC 17025, GLP, GMP
testing for drug development in the phases: drug discovery, preclinical and clinical testing
quality control in pharmaceutical production of biologicals
for market segment: science
cytotoxicity testing
cell lines authentication
detection of mycoplasma
for market segment: public
paternity testing
testing of genetic origin
for market segment: government institutions
expert institute services
Company data
Number of employees20-49
Foundation1995
Area of businessDiagnostics